Skip to content

Efavirenz superior to nevirapine for first-line treatment: African observational cohort

Is there a role for tropism testing in routine HIV care?

HIV-associated immunosuppression increases risk of liver cancer

Once-daily darunavir (Prezista) approved for first-line use in United States

Shorter combination TB preventive regimens may be effective alternative to six-month isoniazid preventive therapy

UK conference discusses ‘disastrous’ impact of the myth of ‘HIV health tourism’

Prebiotics may improve gut health, immune system function, UK conference hears

TB vaccine reduces new cases by almost 40% in people with HIV

Maraviroc fails to make economic case for use by NHS in Scotland